FDA Inspection 1156222 — Baptist Health Hardin
The FDA completed an inspection of Baptist Health Hardin on Oct 29, 2021 in Elizabethtown, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 29, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Elizabethtown, KY (United States)